Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-23T06:24:26.004Z Has data issue: false hasContentIssue false
  • English
  • Français

Venlafaxin for the treatment of psychotic depression

Published online by Cambridge University Press:  16 April 2020

RW Licht  and
P Kassow
RW Licht
Affiliation:
Psychiatric Department A, Psychiatric Hospitial in Aarhus, University of Aarhus, Skovagerve; 2, DK-8210, Risskov, Denmark
P Kassow
Affiliation:
Psychiatric Department A, Psychiatric Hospitial in Aarhus, University of Aarhus, Skovagerve; 2, DK-8210, Risskov, Denmark

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Information
European Psychiatry , Volume 13 , Issue 5 , August 1998 , pp. 276 - 277
Copyright
Copyright © Elsevier, Paris 1998

References

Bolden-Watson, C, Richelson, EBlockade by newly-developed antidepressants of biogenic amine uptake into rat brain synapto-somes Life Sciences 52 1993 1023–1029CrossRefGoogle Scholar
Entsuah, AR, Rudolph, R, Chitra, REffectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis Psychopharmacol Bull 31 1995 759–766Google Scholar
Gatti, F, Bellini, L, Gasperini, M, Perez, J, Zanardi, R, Smeraldi, EFluvoxamine alone in the treatment of delusional depression Am J Psychiatry 153 1996 414–416Google ScholarPubMed
Glassman, AH, Roose, SPDelusional depression: a separate entity Arch Gen Psychiatry 38 1981 424–427CrossRefGoogle Scholar
Sacchetti, E, Conte, G, Guarneri, L, Calzeroni, A, Bertini, M, Pan-ariello, AEffectivness of fluvoxamine and paroxetine in major depressives with psychotic features Hum Psychopharmacol 12 1997 277–2783.0.CO;2-E>CrossRefGoogle Scholar
Schatzberg, AF, Rotschild, AJPsychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 149 1992 733–745Google ScholarPubMed
Spiker, DG, Weiss, JC, Dealy, RS, Griffin, SJ, Hanin, I, Neil, JFThe pharmacological treatment of delusional depression (1985) Am J Psychiatry 142 1985 430–436Google Scholar
Zanardi, R, Franchini, L, Gasperini, M, Perez, J, Smeraldi, EDouble-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression Am J Psychiatry 153 1996 1631–1633Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.